- Fibrolamellar hepatocellular carcinoma
- Eosinophilic hepatocellular carcinoma with lamellar fibrosis
- Polygonal cell hepatocellular carcinoma with fibrous stroma
- Hepatocellular carcinoma with increased stromal fibrosis
- Eosinophilic glassy cell hepatoma
News & Events
ORDR Co-Sponsored Conferences
2016 Rare Disease Day at NIH, Monday, February 29, 2016
Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.
Advancing Symptom Clusters Research on Rare Cancers, Wednesday, June 17, 2015
Location: NIH Neuroscience Building, Bethesda, MD
Description: <p>It is intended that the in-depth, interdisciplinary dialogue of this expert working group will formulate an emerging consensus on a working definition of symptom clusters and, specific gaps and opportunities that provide a foundation for a transformative strategic blueprint to guide future symptom cluster research in rare cancers. In addition, it is anticipated that workshop proceedings will inform a funding opportunity announcement.</p>
Rare Tumors Initiative Symposium Strategies to Develop Therapies for Rare Tumors: Small Numbers, but Big Opportunities , Wednesday, June 17, 2015
Location: NIH Natcher Conference Center, Bethesda, MD
Description: The goals of this symposium are to increase communication and build networks between researchers working in rare tumors across NIH, and to get input from patient groups, industry, and the FDA on how to overcome the biggest hurdles in the development of therapies for rare tumors. The Rare Tumors Initiative at NCI, CCR will use this information to prioritize goals for the future and will prepare a white paper summary to help guide researchers worldwide.
Genetic Diseases of Children: Advancing Research & Care, Monday, March 07, 2011 - Wednesday, March 09, 2011
Location: Sheraton New York Hotel & Towers, New York, NY
Description: The New York State Department of Health announced Genetic Diseases of Children: Advancing Research & Care. This national conference brought together the worlds of health, science, government, and industry with the families who look to them for answers.
Overcoming Barriers to International Clinical Trials for Rare Cancers , Friday, December 10, 2010
Location: Bethesda, Maryland
Description: The goals of this conference were to introduce key institutional players to the topic of international clinical trials in rare cancers and to establish an ongoing dialogue. Participants left the meeting with a set of specific priorities that need to be enacted to promote these trials. The meeting promoted consensus on the way that resources are prioritized to address rare cancers. Participants were asked to convey the content of the meeting to their constituencies and to follow up with pilot concepts.
The 15th International Symposium on Cells of the Hepatic Sinusoid , Saturday, August 28, 2010 - Wednesday, September 01, 2010
Location: Pasadena, California
Description: Studies on the sinusoidal cells are becoming increasingly important in diverse areas ranging from stem cells, liver development and regeneration, and the pathogenesis of liver diseases such as steatohepatitis, fibrosis, and hepatocellular carcinoma (HCC) to therapeutic approaches including liver transplantation. The target audience was both established and junior investigators, graduate students, and postdoctoral fellows who work in these multidisciplinary fields. The symposium helped develop constructive international collaborations that would result in true advantages for people with rare liver diseases.
Workshop on the Etiology of Hepatocellular Carcinoma in the United States, Saturday, April 17, 2010
Location: Embassy Suites Hotel - DC Convention Center, Washington, DC
Description: The goal of this workshop was to assemble investigators of U.S.-based cohort studies in order to form a hepatocellular carcinoma (HCC) pooling project.
Second International Workshop on Cholangiocarcinoma and Hepatocellular Carcinoma, Tuesday, October 06, 2009 - Wednesday, October 07, 2009
Location: Natcher Conference Ctr., NIH Campus, Bethesda, MD
Description: The objective of this workshop was to bring together basic researchers, clinicians, epidemiologists, and bioinformaticians worldwide who are experts in liver cancer biology and genetics study to exchange state-of-the-art and late-breaking discoveries. This meeting provided a forum for both intramural and extramural scientists for a better understanding of the latest research findings and implementation of these findings in diagnosis, treatment, and prevention of liver cancer. This meeting also promoted awareness of liver cancer research to the intramural community.
- The National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, Department of Veteran Affairs, and Fogarty International Center sponsored a conference on hepatocellular carcinoma on April 1-3, 2004 to discuss the screening, diagnosis, and management of this type of cancer. You can view the agenda as well as a list of speakers by clicking here.